Screening children with nf1 for optic pathway glioma – No

Eye (Basingstoke)

Volumn 24, Issue 9, 2010, Pages 1432-1434

  Pilling, R F ^a   Taylor, R H ^b  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^b YORK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; FEMALE; HUMAN; MALE; MASS SCREENING; METHODOLOGY; NEUROFIBROMATOSIS; NOTE; OPTIC NERVE GLIOMA; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MASS SCREENING; NEUROFIBROMATOSIS 1; OPTIC NERVE GLIOMA;

EID: 84984752044     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.94     Document Type: Article

References (14)

1. Listernick R, Ferner R, Liu G, Gurmann D. Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations. Ann Neurol 2007; 61: 189-198.
2. Ferner R. Neurofibromatosis 1 and neurofibromatosis 2: A twenty first century perspective. Lancet Neurol 2007; 6: 340-351.
3. Listernick R, Louis D, Packer R, Gurmann D. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 1997; 41(2): 143-149.
4. Lund A, Skovby F. Optic gliomas in children with neurofibromatosis type 1. Eur J Pedintr 1991; 150: 835-838.
5. Ferner R, Huson S, Thomas N, Moss C, Willshaw H, Evans G et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis. J Med Genet 2007; 44: 81-88.
6. Wolsey DH, Larson SA, Creel D, Hoffman R. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? I Am Assoc Pedintr Ophthalmol Strabismus 2006; 10(4): 307-311.
7. King A, Listernick R, Charrow J, Piersall L, Gutmann DH. Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome. Am J Med Genet A 2003; 1(122A): 95-99.
8. Massry GG, Morgan CF, Chung SM. Evidence of optic pathway gliomas after previously negative neuroimaging. Ophthalmology 1997; 104: 930-935.
9. Blazo M, Lewis R, Chintagumpala M, Frazier M, McCluggage C, Plon S. Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1. Am J Med Genet A 2004; 127A: 224-229.
10. Pepin S, Lessell S. Anterior visual pathway gliomas; the last 30 years. Semin Ophthalmol 2006; 21: 117-124.
11. Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 2003; 2: 262-270.
12. Packer R, Ater J, Allen J. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 1997; 86: 747-754.
13. Listernick R, Charrow J, Gutmann DH. Comments on neuro-fibromatosis 1 and optic pathway tumors. Am J Med Genet A 2001; 102: 105.
14. Kelly JP, Weiss AH. Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas. J AAPOS 2006; 10: 298–306.